Gemma Brown

CFO at Vaccitech

Gemma is an experienced financial executive who joined Vaccitech as its Head of Financial Reporting in 2021, before her promotion to CFO in September 2022.

Prior to joining Vaccitech, Gemma spent 9 years at EY where she held positions of increasing responsibility, reaching the level of Senior Manager in 2019 and participating in their accelerated leadership programs.

While at EY, Gemma worked with clients across the US and UK capital markets and was responsible for servicing several emerging biopharmaceutical companies that achieved listings on Nasdaq, either through IPO or M&A transactions. She has a B.Sc. in Biological Sciences and is a Chartered Accountant with the Institute of Chartered Accountants in England & Wales.

Location

Henley-on-Thames, United Kingdom

Links


Org chart


Teams


Offices

This person is not in any offices


Vaccitech

1 followers

Vaccitech is a clinical stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. The company’s proprietary technology platform, comprising Chimpanzee Adenovirus (prime) and MVA (boost) is exceptional at inducing, boosting and maintaining CD8+ and CD4+ T cells, as well as antibodies.


Industries

Employees

51-200

Links